These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 12018929)
1. The current state of hormonal therapy for prostate cancer. Hellerstedt BA; Pienta KJ CA Cancer J Clin; 2002; 52(3):154-79. PubMed ID: 12018929 [TBL] [Abstract][Full Text] [Related]
2. Hormonal therapy trials in prostatic cancer. An EORTC Genitourinary Group study. Bollack C; Rougeron G Am J Clin Oncol; 1988; 11 Suppl 2():S156-9. PubMed ID: 2977270 [TBL] [Abstract][Full Text] [Related]
3. Hormonal management of advanced adenocarcinoma of the prostate. Miles BJ Henry Ford Hosp Med J; 1989; 37(1):16-8. PubMed ID: 2670839 [No Abstract] [Full Text] [Related]
9. [Hormonal treatment of advanced cancer of the prostate]. de Leval J Rev Med Liege; 1991 Nov; 46(11):577-82. PubMed ID: 1754776 [No Abstract] [Full Text] [Related]
10. Carcinoma of the prostate: neoadjuvant hormonotherapy followed by radiotherapy. Scalliet P Acta Urol Belg; 1996 May; 64(2):63-4. PubMed ID: 8701815 [No Abstract] [Full Text] [Related]
11. Hormonal therapy options for patients with a rising prostate-specific antigen level after primary treatment for prostate cancer. Hellerstedt B Urology; 2003 Dec; 62 Suppl 1():79-86. PubMed ID: 14747045 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in hormonal therapy for advanced prostate cancer. Oottamasathien S; Crawford ED Oncology (Williston Park); 2003 Aug; 17(8):1047-52; discussion 1054-8. PubMed ID: 12966672 [TBL] [Abstract][Full Text] [Related]
13. [Hormonal therapy of prostatic cancer: current status of the problem]. Veliev EI; Okhrits VE Urologiia; 2011; (4):64-8. PubMed ID: 22066246 [No Abstract] [Full Text] [Related]
15. [New hormonal treatments of metastatic prostatic cancer. Review of the literature]. Dubost JJ; Sauvezie B; Ristori JM; Thevenet JP; Rampon S Rev Rhum Mal Osteoartic; 1985 Oct; 52(10):577-85. PubMed ID: 3909364 [No Abstract] [Full Text] [Related]
16. The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer. Scherr DS; Pitts WR J Urol; 2003 Nov; 170(5):1703-8. PubMed ID: 14532759 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Zoladex, diethylstilbestrol and cyproterone acetate treatment in advanced prostate cancer. Moffat LE Eur Urol; 1990; 18 Suppl 3():26-7. PubMed ID: 2151272 [No Abstract] [Full Text] [Related]
18. Androgen deprivation therapy for prostate cancer: current status and future prospects. Miyamoto H; Messing EM; Chang C Prostate; 2004 Dec; 61(4):332-53. PubMed ID: 15389811 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of cancer of the prostate. New hormonal approaches]. Schaison G Pathol Biol (Paris); 1989 Feb; 37(2):118-9. PubMed ID: 2523530 [No Abstract] [Full Text] [Related]
20. Current status of neoadjuvant therapy in localized prostate cancer. Witjes WP; Oosterhof GO; Schaafsma HE; Debruyne FM Prostate; 1995 Dec; 27(6):297-303. PubMed ID: 7501541 [No Abstract] [Full Text] [Related] [Next] [New Search]